These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 24486372)

  • 1. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
    Ishikawa T; Yamanaka A; Konishi E
    Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flaviviruses and flavivirus vaccines.
    Heinz FX; Stiasny K
    Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
    Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
    J Virol; 2020 May; 94(10):. PubMed ID: 32132233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of flavivirus vaccines.
    Barrett AD
    Ann N Y Acad Sci; 2001 Dec; 951():262-71. PubMed ID: 11797783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue and other emerging flaviviruses.
    Solomon T; Mallewa M
    J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in flavivirus vaccines with special attention to yellow fever.
    Pugachev KV; Guirakhoo F; Monath TP
    Curr Opin Infect Dis; 2005 Oct; 18(5):387-94. PubMed ID: 16148524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in flavivirus vaccine development.
    Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
    IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging vector-borne flavivirus diseases: are vaccines the solution?
    Gubler DJ
    Expert Rev Vaccines; 2011 May; 10(5):563-5. PubMed ID: 21604976
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advancement in flavivirus vaccine development.
    Chang GJ; Kuno G; Purdy DE; Davis BS
    Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flavivirus infections: yellow fever, dengue fever and Japanese encephalitis].
    Buhl MR
    Ugeskr Laeger; 2005 Oct; 167(43):4076-80. PubMed ID: 16251091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional and novel approaches to flavivirus vaccines.
    Pugachev KV; Guirakhoo F; Trent DW; Monath TP
    Int J Parasitol; 2003 May; 33(5-6):567-82. PubMed ID: 12782056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live flavivirus vaccines: reasons for caution.
    Seligman SJ; Gould EA
    Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research advances in plant-made flavivirus antigens.
    Martínez CA; Giulietti AM; Talou JR
    Biotechnol Adv; 2012; 30(6):1493-505. PubMed ID: 22480936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal Vaccination: A Promising Alternative Against Flaviviruses.
    Luria-Pérez R; Sánchez-Vargas LA; Muñoz-López P; Mellado-Sánchez G
    Front Cell Infect Microbiol; 2022; 12():887729. PubMed ID: 35782117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Perspective on Current Flavivirus Vaccine Development: A Brief Review.
    Dutta SK; Langenburg T
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavivirus DNA vaccines: current status and potential.
    Chang GJ; Davis BS; Hunt AR; Holmes DA; Kuno G
    Ann N Y Acad Sci; 2001 Dec; 951():272-85. PubMed ID: 11797784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse and hamster models for the study of therapy against flavivirus infections.
    Charlier N; De Clercq E; Neyts J
    Novartis Found Symp; 2006; 277():218-29; discussion 229-32, 251-3. PubMed ID: 17319165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial.
    Sandberg JT; Löfling M; Varnaitė R; Emgård J; Al-Tawil N; Lindquist L; Gredmark-Russ S; Klingström J; Loré K; Blom K; Ljunggren HG
    PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010616. PubMed ID: 36758067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.